SCHEMBL1750871

SCHEMBL1750871

Cc1cccc(N2CCC(=O)CC2=O)c1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
ALOX5 P09917 3/20 0.49
MAPT P10636 2/20 0.48
HSD17B10 Q99714 1/20 0.48
HSD11B1 P28845 3/20 0.46
HSP90AA1 P07900 1/20 0.45
MGLL Q99685 1/20 0.45
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
CASP6 P55212 1/20 0.44
KMT2A Q03164 1/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
ADRB1 P08588 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9564052 0.86 L3MBTL1 (0.62) L3MBTL1ALOX5MAPTHSD17B10HSD11B1
SCHEMBL1751576 0.82 ALOX5 (0.47) ALOX5MAPTHSD11B1MGLLMEN1
SCHEMBL1459903 0.80 ALDH1A1 (0.62) L3MBTL1ALOX5MEN1GAAKMT2A
SCHEMBL1750928 0.79 NPC1 (0.52) L3MBTL1ALOX5MAPTHSD11B1MEN1
SCHEMBL12795836 0.79 L3MBTL1 (0.57) L3MBTL1ALOX5MAPTHSD17B10HSD11B1
SCHEMBL25575682 0.76 L3MBTL1 (0.54) L3MBTL1ALOX5MAPTHSD17B10HSD11B1
SCHEMBL1360758 0.76 ADRB1 (0.61) L3MBTL1ALOX5MAPTHSD17B10HSP90AA1
SCHEMBL6401435 0.75 L3MBTL1 (0.53) L3MBTL1ALOX5MAPTHSD17B10HSD11B1
SCHEMBL12879707 0.74 L3MBTL1 (0.51) L3MBTL1ALOX5MAPTHSD17B10HSD11B1
SCHEMBL22941454 0.74 CRBN (0.69) L3MBTL1ALOX5MAPTHSD17B10HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269715-A1 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE ALLERGAN, INC. 2011-11-03 US disclosed
US-7968711-B2 Isoprenyl-3-methylcyclohex-2-enyl)benzene-1,3-diol, 2-(3,5-Difluorophenyl)-5-hydroxypyridazin-3-one, 4-Bromo-2-(2,5-dichlorophenyl)-5-hydroxypyridazin-3-one; glaucoma or ocular hypertension ALLERGAN, INC. (US) 2011-06-28 US disclosed
EP-2123264-A1 Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure Allergan, Inc. (US) 2009-11-25 EP disclosed
EP-2010165-A2 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE Allergan, Inc. (US) 2009-01-07 EP disclosed
WO-2007127711-A2 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE ALLERGAN, INC. (US) 2007-11-08 WO disclosed
US-20070249596-A1 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE ALLERGAN, INC. 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249596-A1 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE CNR2, CNR1, PTGIR L3MBTL1 4422/4885ALOX5 430/4885MAPT 1486/4885
US-20110269715-A1 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE CNR2, CNR1, PTGIR L3MBTL1 4422/4885ALOX5 430/4885MAPT 1486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.